What is the current Celldex Therapeutics market capitalization?
The current market capitalization of Celldex Therapeutics is 1.72 B USD.
Celldex Therapeutics Market capitalization 2024
Celldex Therapeutics Market capitalization
1.72 B USD
Ticker
CLDX
ISIN
US15117B2025
WKN
A2PEAB
In 2024, Celldex Therapeutics's market cap stood at 1.72 B USD, a -3.47% increase from the 1.78 B USD market cap in the previous year.
The Celldex Therapeutics Market capitalization history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) | NET INCOME (undefined USD) |
|---|---|---|---|
| 2029e | 870.14 | 0,41 | 75.97 |
| 2028e | 413.61 | 0,87 | -123.03 |
| 2027e | 60.2 | 5,96 | -246.06 |
| 2026e | 2.3 | 156,43 | -243.5 |
| 2025e | 2.83 | 126,81 | -198.1 |
| 2024e | 2.77 | 129,42 | -155.63 |
| 2023 | 6.88 | 52,16 | -141.43 |
| 2022 | 2.36 | 152,12 | -112.33 |
| 2021 | 4.65 | 77,20 | -70.51 |
| 2020 | 7.42 | 48,38 | -59.78 |
| 2019 | 3.57 | 100,56 | -50.88 |
| 2018 | 9.54 | 37,63 | -151.18 |
| 2017 | 12.74 | 28,18 | -93.03 |
| 2016 | 6.79 | 52,87 | -128.53 |
| 2015 | 5.48 | 65,51 | -127.2 |
| 2014 | 3.59 | 100,00 | -118.08 |
| 2013 | 4.11 | 43,31 | -81.55 |
| 2012 | 11.2 | 3,84 | -59.12 |
| 2011 | 9.27 | 1,62 | -44.8 |
| 2010 | 46.79 | 74,20 | -2.53 |
| 2009 | 15.18 | 44,66 | -36.53 |
| 2008 | 7.46 | 50,27 | -47.5 |
| 2007 | 1.41 | 254,61 | -15.07 |
| 2006 | 0.9 | 398,89 | -17.83 |
| 2005 | 3.09 | 116,18 | -18.1 |
| 2004 | 6.86 | 100,00 | -13.2 |
Celldex Therapeutics Aktienanalyse
What does Celldex Therapeutics do?
Celldex Therapeutics is an American company specializing in the development and research of therapeutics for diseases of the immune system and cancer. The company was founded in 2004 and is headquartered in Hampton, New Jersey. Celldex Therapeutics was originally established as a subsidiary of Alteon Inc., which focused on developing drugs for heart diseases. In 2004, the company became independent. Celldex Therapeutics has continuously invested in the development of new medicines for various areas of oncology. Its business model is based on the development and marketing of innovative therapeutics. The company collaborates closely with leading research institutions in the field of immunology and oncology to develop new therapies. Celldex Therapeutics also has partnerships with major pharmaceutical companies such as Pfizer, Roche, and Bristol-Myers Squibb. The company is divided into different divisions, including the development of vaccines and immunotherapies for various types of cancer, as well as the development of protein therapeutics for the treatment of inflammatory diseases and other immune system disorders. Celldex Therapeutics has already launched several products or is currently developing them, including CDX-1127, a immunomodulatory antibody for cancer treatment; CDX-1135, a novel vaccine against the Epstein-Barr virus; CDX-1401, an immunotherapy for various types of cancer based on dendritic cells; and Glembatumumab vedotin, an antibody-drug conjugate for the treatment of different types of cancer. In summary, Celldex Therapeutics is a biotech company specialized in innovative therapies for cancer and immune system diseases. The company collaborates with research institutions and pharmaceutical companies to bring its products to patients. Its wide portfolio and expertise contribute to improving patient care. Celldex Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Celldex Therapeutics's Market Capitalization
Celldex Therapeutics's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Celldex Therapeutics's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Celldex Therapeutics's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Celldex Therapeutics’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Celldex Therapeutics stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Celldex Therapeutics.
How has the market capitalization of Celldex Therapeutics developed in recent years?
The market capitalization of Celldex Therapeutics has increased/decreased by -3.47% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Celldex Therapeutics?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Celldex Therapeutics?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Celldex Therapeutics have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Celldex Therapeutics pay?
Over the past 12 months, Celldex Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Celldex Therapeutics is expected to pay a dividend of 0 USD.
What is the dividend yield of Celldex Therapeutics?
The current dividend yield of Celldex Therapeutics is .
When does Celldex Therapeutics pay dividends?
Celldex Therapeutics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Celldex Therapeutics?
Celldex Therapeutics paid dividends every year for the past 0 years.
What is the dividend of Celldex Therapeutics?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Celldex Therapeutics located?
Celldex Therapeutics is assigned to the 'Health' sector.
Wann musste ich die Aktien von Celldex Therapeutics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Celldex Therapeutics from 7/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/8/2024.
When did Celldex Therapeutics pay the last dividend?
The last dividend was paid out on 7/8/2024.
What was the dividend of Celldex Therapeutics in the year 2023?
In the year 2023, Celldex Therapeutics distributed 0 USD as dividends.
In which currency does Celldex Therapeutics pay out the dividend?
The dividends of Celldex Therapeutics are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Celldex Therapeutics stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Celldex Therapeutics
Our stock analysis for Celldex Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Celldex Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Celldex Therapeutics Revenue
- Celldex Therapeutics Net Income
- Celldex Therapeutics P/E
- Celldex Therapeutics P/S
- Celldex Therapeutics EBIT
- Celldex Therapeutics Dividend
- Celldex Therapeutics Stocks
- Celldex Therapeutics Market capitalization
- Celldex Therapeutics Debt
- Celldex Therapeutics Liabilities
- Celldex Therapeutics Equity
- Celldex Therapeutics AAQS
- Celldex Therapeutics Employees
- Celldex Therapeutics ROE
- Celldex Therapeutics ROA
- Celldex Therapeutics ROCE
